Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Armağan Kutlay"'
Publikováno v:
Indian Journal of Dermatology
Indian Journal of Dermatology, Vol 64, Iss 5, Pp 392-399 (2019)
Indian Journal of Dermatology, Vol 64, Iss 5, Pp 392-399 (2019)
Background: The frequency of clinicoepidemiological variants of Kaposi's sarcoma (KS) differs markedly throughout the world. The iatrogenic variant is mainly associated with the use of immunosuppressive therapy. Aims: We aimed to investigate the dist
Publikováno v:
Dermatologic therapyREFERENCES. 34(4)
There is a paucity of data on long-term (≥5-year) outcomes of ustekinumab therapy for psoriasis in real-life clinical practice. This observational, retrospective study aimed to evaluate the long-term efficacy and safety profile of ustekinumab in 52
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35
Publikováno v:
Dermatologic Therapy.
Doxepin is an old tricyclic antidepressant, whose efficacy in chronic urticaria had been well documented until 1990. However, over the past three decades, there has been limited data on its use. We aimed to assess the efficacy and safety of doxepin i
Publikováno v:
Contact Dermatitis. 78:97-99
Publikováno v:
Contact dermatitis. 78(1)
Autor:
Armagan Kutlay, Afet Akdag Kose
Publikováno v:
Indian Journal of Dermatology, Vol 68, Iss 4, Pp 372-376 (2023)
Background: Elafin is a serine protease inhibitor with anti-inflammatory properties. It is expressed in various epithelial tissues with increased production under inflammatory conditions. Increased tissue elafin expression in Behçet's disease (BD) l
Externí odkaz:
https://doaj.org/article/38f8ac029b1149cea8dbfd9ab91439d4
Publikováno v:
Dermatologic Therapy. :e12934
Autor:
Armağan Kutlay, Esen Özkaya
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 31:e443-e444
Publikováno v:
Dermatologic Therapy. 31:e12674